There's a difference between a strategic placement to block a takeover run in the industry or to benefit from a40 upside price wise. But in my opinion, companies don't share experience or potential trade secrets with a smaller less experienced competitor / rival without much higher exposure. The more I consider its a chance to see how the two companies can closely work together for a BH JV. If a JV doesn't pan out a TO. Is a possibility. Or GXY may be content if there's another A40 placement available in 6 months.
DYOR
- Forums
- ASX - By Stock
- GXY
- Ann: A40: $32.5m Strategic Institutional Placements
Ann: A40: $32.5m Strategic Institutional Placements, page-129
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online